Besides the direct targeting of HIF-1α, a significant decrease in HIF-1α at both transcriptional and translational levels in 2-ANPC-treated cancer cells might be due to its previously demonstrated ability to alter microtubule dynamics and inhibit tubulin polymerization. The gene discussed is HIF1A; the disease is cancer.